EFL033 - GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes

  Рет қаралды 216

Endocrine Society

Endocrine Society

Күн бұрын

Пікірлер: 2
@karolayochoa7318
@karolayochoa7318 2 ай бұрын
Hi How come the patient were going into DKA if there A1c and sugar were in range?!
@TheEndocrineSociety
@TheEndocrineSociety 2 ай бұрын
Thank you for your interest. Questions can be directed towards podcast@endocrine.org
Cardiovascular Benefits of GLP-1 RAs
26:15
American Heart Association
Рет қаралды 1,6 М.
LADA (Latent Autoimmune Diabetes in Adults)
30:31
Taking Control Of Your Diabetes
Рет қаралды 18 М.
Who’s the Real Dad Doll Squid? Can You Guess in 60 Seconds? | Roblox 3D
00:34
Não sabe esconder Comida
00:20
DUDU e CAROL
Рет қаралды 35 МЛН
А что бы ты сделал? @LimbLossBoss
00:17
История одного вокалиста
Рет қаралды 10 МЛН
Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024
1:07:25
Stanford Department of Medicine
Рет қаралды 5 М.
Diabetes Mellitus | Clinical Medicine
44:57
Ninja Nerd
Рет қаралды 206 М.
Chronic Kidney Disease and GLP-1 RAs
28:17
American Heart Association
Рет қаралды 1,4 М.
the Diabetes episode | Beaumont HouseCall Podcast
31:45
Corewell Health in Southeast Michigan
Рет қаралды 53 М.
Ben Bikman, PhD | Reversing Insulin Resistance | The Metabolic Link Ep.9
1:12:45
Metabolic Health Summit
Рет қаралды 260 М.